NASDAQ:NEOG

Track all markets on TradingView - Prices are not updated in real time
Neogen Jumps 11% Premarket After Strong Q1 Growth and Raised Fiscal 2027 Guidance

Neogen (NASDAQ: NEOG) shares surged about 11% in premarket trading after the food safety company reported stronger first-quarter fiscal 2027 results and raised its full-year revenue and adjusted EBITDA outlook.

First-quarter revenue increased 6.5% year over year to $222.8 million, while core growth reached 8.1%. Food Safety revenue rose 7.4% to $163.2 million and Animal Safety revenue increased 4.2% to $59.6 million, with both segments posting roughly 8% core growth.

Profitability also improved on an adjusted basis. Adjusted EBITDA rose to $41.6 million from $35.5 million a year earlier, while adjusted EBITDA margin expanded to 18.7% from 17.0%. Adjusted net income increased to $17.5 million, or $0.08 per share, from $9.5 million, or $0.04 per share, in the prior-year quarter.

The company still reported a GAAP net loss of $11.9 million, or $0.05 per share, compared with net income of $36.3 million a year earlier, though the prior-year result benefited from a non-cash gain tied to a divestiture.

Operational progress also supported sentiment. Neogen said it remains on track to begin the planned multi-quarter transfer of Petrifilm manufacturing to its Lansing facility in November 2026, with the first SKU already fully validated.

The strongest catalyst appears to be the guidance increase. Neogen now expects fiscal 2027 revenue of $885 million to $890 million, up from $880 million to $885 million previously, and adjusted EBITDA of $181 million to $183 million, compared with prior guidance of $180 million to $182 million.

The combination of solid core growth, margin expansion, improving execution and higher full-year guidance appears to be driving the sharp premarket move.
💬
Author
European Investor 10-07-26
**Neogen Posts Q3 Loss Despite Stable Revenue, Raises Full-Year Outlook**

Neogen Corporation reported fiscal third-quarter 2026 revenue of $211.2 million, with modest growth in its Food Safety segment offset by a sharp decline in Animal Safety performance.

The company posted a net loss of $17.0 million, or $(0.08) per share, while adjusted net income reached $19.4 million, with adjusted EPS of $0.09. Adjusted EBITDA came in at $48.2 million, with margins improving to 22.8%.

Food Safety revenue increased 2.6%, supported by solid core growth, while Animal Safety revenue dropped 20.1%, primarily due to third-party supplier disruptions. Despite these challenges, Neogen generated operating cash flow of $22.7 million and free cash flow of $11.1 million.

The company said it remains on track with key strategic initiatives, including the Petrifilm manufacturing transition and the planned divestiture of its Genomics unit. Neogen also raised its full-year revenue outlook while maintaining its adjusted EBITDA guidance, signaling confidence in a recovery driven by operational improvements and cost controls.
Business Wire
💬
Author
European Investor 04-09-26
Neogen Corporation reported second-quarter fiscal 2026 results showing improving profitability and core growth momentum, despite headline revenue declining amid portfolio changes and macro headwinds.

Revenue for the quarter ended November 30, 2025, totaled $224.7 million, down 2.8% year over year, while core revenue—excluding currency effects, divestitures, and discontinued products—grew 2.9%. The company posted a net loss of $15.9 million, or $0.07 per share, a significant improvement from a large prior-year loss driven by a non-cash goodwill impairment. Adjusted net income came in at $22.6 million, or $0.10 per share. Adjusted EBITDA was $48.7 million, with the adjusted EBITDA margin improving 470 basis points sequentially to 21.7%.

Gross margin declined to 47.5% from 49.0% a year earlier, reflecting tariff costs, inventory write-offs, and product mix, partially offset by lower operating expenses. Neogen highlighted progress in its strategic transformation, including the hiring of senior commercial leaders and continued execution of the Petrifilm manufacturing transition, which management said remains on track.

Segment performance was mixed. Food Safety revenue increased 0.8% year over year to $165.6 million, supported by strong core growth in Indicator Testing, Culture Media, and pathogen detection products. Animal Safety revenue fell 11.8% to $59.1 million, largely due to divestitures, though core growth was supported by biosecurity products. Citing sequential improvements and operational progress, Neogen raised its full-year fiscal 2026 revenue and adjusted EBITDA guidance.
💬
Author
WS Investor 01-08-26
Neogen Reports First-Quarter 2026 Results, Reaffirms Full-Year Outlook

Neogen Corporation reported first-quarter 2026 revenue of 209.2 million dollars and net income of 36.3 million dollars, with adjusted net income of 9.4 million and adjusted EBITDA of 35.5 million. The company completed the divestiture of its Cleaners & Disinfectants business, repaid 100 million dollars of debt, and implemented restructuring measures to streamline costs. Newly appointed CEO Mike Nassif emphasized a renewed focus on commercial execution, innovation, and efficiency to strengthen Neogen’s position in food and animal safety markets. The company reaffirmed its full-year financial guidance.
💬
Author
The Investor 10-09-25
Neogen Announces Retirement and Appointment to Board of Directors

Neogen Corporation announced that James P. Tobin will retire from the Board of Directors effective May 31, 2025. Tobin has served since 2016, including as Chair of the Governance and Sustainability Committee and member of the Audit Committee. Board Chair James C. Borel will act as interim Chair of the Governance and Sustainability Committee.

Andrea Wainer, former Executive Vice President of Rapid and Molecular Diagnostics at Abbott Laboratories, will join the Board as a Class II director on June 1, 2025. She will also serve on the Governance and Sustainability and Science, Technology, and Innovation Committees. Wainer currently serves as a director of Analog Devices, Inc.
💬
M
ME NEWS 05-13-25
Neogen CEO John Adent to Step Down; Search for Successor Underway

Neogen Corporation announced that CEO and President John Adent will step down after eight years in the role. He will remain in position until a successor is appointed. The company’s board has formed a special search committee and hired an executive search firm to oversee the transition.

Board Chair Jim Borel expressed appreciation for Adent’s leadership, noting that Neogen is well-positioned to advance its strategic initiatives and capitalize on growth opportunities in the food safety market. Adent emphasized his pride in the company’s progress and pledged continued focus on performance and a smooth leadership transition.

Neogen, a global provider of food and animal safety solutions, operates in over 140 countries and continues to prioritize innovation and portfolio optimization.
💬
Author
WS News 04-10-25
Neogen Announces Refinancing of Term Loan and Credit Facility, Extending Maturities and Reducing Interest Costs

Neogen Corporation has successfully refinanced its remaining $550 million term loan and revolving credit facility ahead of their August 2027 maturities. The new financing includes a $450 million term loan and a $250 million revolving credit facility, both maturing in April 2030. This move extends maturity timelines by more than two and a half years and increases the revolving credit capacity by $100 million.

With a new interest rate of SOFR plus 175 basis points—60 basis points lower than before—the transaction is leverage-neutral and provides greater balance sheet flexibility. JPMorgan Chase led the refinancing alongside BofA Securities, Citizens Bank, Goldman Sachs, and Wells Fargo.

Neogen’s CFO and COO David Naemura highlighted the deal as a strategic step to preserve liquidity, reduce financing costs, and support the company’s financial agility. Neogen continues to deliver food safety and animal health solutions across more than 140 countries.
💬
Author
Global Finance News 04-08-25